Indianapolis firm MindX Sciences is working to develop apps and blood tests for an objective assessment of mental health issues and pain levels , enabling doctors to better match patients and treatments . Mind Sciences ' tests are based on the analysis of blood biomarkers for suicide risk , post - traumatic stress disorder and depression , among others , and will eventually help pharma companies develop new drugs .
Indianapolis firm MindX Sciences is working to commercialise apps and blood tests offering an objective assessment of mental health issues and pain levels, enabling clinicians to better match patients and treatments. MindX Sciences' tests are based on the identification of blood biomarkers for suicide risk, post-traumatic stress disorder and depression, among others, and could eventually help pharma companies develop new drugs.